Monte Rosa Therapeutics, Inc. (GLUE) Net income 2021–2026
Monte Rosa Therapeutics, Inc. (GLUE) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$38.6MFY2026 · since FY2021: -$35.9M → -$38.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$38.6M | +46.9% |
| FY2025 | -$72.7M | +46.3% |
| FY2024 | -$135.4M | -24.7% |
| FY2023 | -$108.5M | -46.7% |
| FY2022 | -$74.0M | -106.1% |
| FY2021 | -$35.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice